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A Chemoattractant Receptor on
Macrophages Exists in Two Affinity States
Regulated by Guanine Nucleotides
ABSTRACT
￿
The binding characteristics of the oligopeptide chemoattractant receptor on guinea
pig macrophages and macrophage membrane preparations were characterized using detailed
binding studies and computer analysis. Viable macrophages bound the radiolabeled che-
moattractant N-formyl-methionyl-leucyl-[ 3 H]phenylalanine with single dissociation constant
(Ko) of 18.4 ± 4 .6 nM with 15,300 ± 1,800 sites per cell. Binding data from membrane
preparations indicated the presence of two classes of binding sites with Kp of 1 .5 ± 0.4 nM
and 25.5 ± 11 .0 nM. Approximately 23% of the receptors were in the high affinity state. In
the presence of added guanine nucleotide di- or triphosphates, the high affinity receptors in
the membrane preparations were converted to low affinity states with no change in the total
receptor number. Nonhydrolyzable derivatives of GTP were most potent in converting the
receptor from its high to low affinity state. These data suggest that the affinity state of the
oligopeptide chemoattractant receptor in macrophages is regulated by guanine nucleotides
and GTPase, implying that the transduction mechanisms of this receptor may be controlled
by a guanine nucleotide regulatory unit.
Macrophages are motile cells capable of migrating along
increasing gradients of chemoattractants. Higher concentra-
tions of chemotactic factors than those required to initiate
directed migration stimulate these cells to secrete lysosomal
enzymes and produce superoxide anions (15). Several years
ago we demonstrated that macrophage chemotaxis was initi-
ated by the binding ofchemoattractants to specific cell surface
receptors (14). To understand how complex biological re-
sponses in macrophages are initiated by chemotactic stimuli,
it will be important to delineate the binding characteristics of
this receptor in detail and to identify its means ofregulation.
To this end we have developed methods for studying receptor-
chemoattractant interactions in macrophage membrane prep-
arations as well as in intact cells. Similar types of receptor
analysis have been instrumental for characterizing the trans-
duction mechanisms of other hormone-receptor systems, par-
ticularly those involving the neurotransmitters (20).
This manuscript describes studies of the binding of the
chemoattractant N-formyl-methionyl-leucyl-['H]phenylala-
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nine (FML['H]P)' to guinea pig peritoneal macrophages and
membrane preparations thereof using a computer program,
SCTFIT, to analyze binding data (5). The program allows
rigorous statistical analysis of binding data and is particularly
useful for the study of receptors that may exist in multiple
affinities(3). These methods were also used to determine the
role of nucleotides in the regulation ofthe macrophage chem-
otactic factor receptor.
MATERIALS AND METHODS
Chemicals:
￿
FML['H]P (specific activity 46.7 Ci/mmol) was purchased
from New England Nuclear(Boston, MA). Guanylyl-imidodiphosphate(p[NH]
'Abbreviations used in this paper. AMP, adenosine-5'-monophos-
phate; FMLP, N-formyl-methionyl-leucyl-phenylalanine; FML['H]P,
N-formyl-methionyl-leucyl-['H]phenylalanine ; GDP, guanosine 5'-
diphosphate; GMP, guanosine-5'-monophosphate; GTP, guano" ~ne-
5'-triphosphate; GTPyS, guanosine-5'-0-3-thiotriphosphate; P?ASF,
phenylmethylsulfonyl fluoride; p[NH]ppG, guanylyl-imidod.phos-
phate.
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m The Rockefeller University Press - 0021-9525/84/02/0444/05 $1.00ppG) and guanosine-5'-0-3-thiotriphosphate (GTP-yS) were obtained from
Boehringer Mannheim (Mannheim, Federal Republic of Germany). Guano-
sine-5'-triphosphate (GTP), guanosine-5'-diphosphate (GDP), guanosine-5'-
monophosphate (GMP), and adenosine-5'-monophosphate (AMP), shellfish
glycogen, phenylmethylsulfonyl fluoride (PMSF), and N-formyl-methionyl-
leucyl-phenylalanine (FMLP) were purchased from Sigma Chemical Co. (St.
Louis, MO).
Cell Preparation:
￿
Inflammatory macrophages were obtained by peri-
toneallavage of male Hartley (Camm Research, Wayne, NJ)guinea pigs, 400-
600 g, 3 d after intraperitoneal injection with 30 ml of0.75% (wt/vol) shellfish
glycogen in isotonic saline (6). The cells were subjected to hypotonic lysis and
the resulting cell populationscontained -90% macrophages. FML['H]P bind-
ing to intact cells was performed at cell concentrations of 1.5 x l06/ml in
incubation buffer, (0.14 M NaCl, 1.9 mM KH2PO4, 5.1 mM Na2HP04, 0.15
mM CaC12, and 0.5 MM MgC12, pH 7.4) plus l mM PMSF. Nonspecific
binding, which was ^-6% of total binding in the presence of PMSF, was
empirically found to be 50% greater in the absence ofPMSF.
Membrane Preparation:
￿
Membranes were prepared by the method
of Davies et al. (2). Macrophages were eususpendnd in 30 ml ofice-cold buffer
(50 mM Tris, 10 MM M9C12, pH 7.7) and disrupted twice with a Tekmar
polytron (Tekmar Co., Cincinnati, OH) for 20 s. This suspension was centri-
fuged at 200 g for 10 min at 4°C, the pellet discarded, and the supernatant
centrifuged at 41,000 g for 10 min at 4°C. This pellet was washed twice by
resuspending with a teflon pestle in 30 ml of Tris buffer(50 mM Tris, 10 mM
MgC12, pH 7.4). Final membrane preparations contained -0.5 mg protein/ml
in Tris buffer, pH 7.4. 5' nucleotidase levels in the membrane preparation were
enhanced approximately 5.1-fold above the levels present in crude cell homog-
enates and 10-fold above the levels in the cytosolic fraction.
FML[3H]P Binding Assay:
￿
Membranes or cells were incubated in a
total volume of 0.15 ml buffer containing 0.25-40 nM FML['H]P in the
presence and absence of 100,uM unlabeled FMLP (21). Incubations were at
25°C for 25 min (membranes) or 60 min (intact cells). The incubation times
were chosen in accord with the requirements for binding to reach steady state.
In experiments where nucleotide effects on binding were studied, membrane
preparations were preincubated with the indicated compounds at 25°C for 20
minbefore addition to FML['H]Pandwere presentduring theentireincubation
period. Binding was terminated by rapid vacuum filtration onto Titertek
harvester(Flow Laboratories, McLean, VA) filters followed by washing with t l
ml ofice-cold buffer. Radioactivity on the filters was counted in an Intertech-
nique scintillation counter (IN/US Service Corp., Fairfield, NJ) with a 60%
countingefficiency.
Computer Modeling:
￿
Data from binding isotherms ofFML['H]P to
intact cells and membranes was computer modeled using the method of
Hancock et al. (5). The program, SCTFIT, is based on the principle of mass
action ligand-receptor interactions and uses a nonlinear least squares curve
fitting method (4). This model allows for analysis of receptors that may exist
in multiple affinity states. All data were analyzed using a one- and two-site
model. The two-site model was accepted only when the fit to the data was
significantly improved (P < 0.01) on the basis of the lowest values of mean
squares of residuals. Affinity constants and concentrations of each class of
receptors represent the geometric means ± SE (3).
Intracellular Nucleotide Levels:
￿
Inflammatory macrophages were
prepared as described above, pelleted, and frozen in liquid nitrogen. The pellet
was extracted with 6% trichloroaceticacid and the supernatant neutralizedwith
tri-N-octylamine in Freon. The aqueous phase was analyzed for nucleotide
levels on a Whatman Partisil-10 SAX (Whatman, Inc., Clifton, NJ) anion
exchange column using high-pressure liquid chromatography (12). The intra-
cellular guanine nucleotide levels were: GMP <2.4,uM, GDP = 67 uM, GTP
= 144 ;LM. The intracellular adenine nucleotide levels were AMP = 70 uM,
ADP = 293 ALM, ATP = 1 mM.
RESULTS
FML(3H]P Binding to Intact Macrophages
Inflammatory macrophages contain on their surface spe-
cific saturable receptors for the oligopeptide chemotactic fac-
tor FML[3H]P (14). To better characterize these receptors, we
incubated various concentrations of FML[3H]P with intact
guinea pig macrophages and the binding isotherms were com-
puter modeled. Fig. 1 illustrates one such binding isotherm,
the data of which were demonstrable of a single class of
receptor sites. The dissociation constant (KD) was 24.6 nM
with 17,800 receptors per cell. The KD determined by Scat-
chard analysis was 29.5 nM with 16,900 receptors per cell,
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FIGURE 1
￿
Binding isotherm of FML[3H]P to intact macrophages.
O, total ligand bound. ", nonspecific binding defined as the amount
of radioligand bound in the presence of 100 pM unlabeled ligand.
The lines through the open and closed circles are the computer
derived best fits for the total binding and nonspecific binding,
respectively. A KD of 24.6 nM and 17,800 receptors per cell were
determined from this data.
0
values in good agreement with those derived by SCTFIT. In
nine computer modeled experiments, intact macrophages
were shown to have an average of 15,300 ± 1,000 receptors
with a single affinity of 18.4 ± 4.6 nM.
FML~3H]P Binding to Macrophage
Membrane Preparations
Binding studies of FML[3H]P to macrophage membrane
preparations were also performed and Fig. 2 represents a
typical binding isotherm. These data suggest heterogeneity of
binding sites and are compatible with two populations of
receptors with different affinity states. The dotted line repre-
sents the computer derived best fit to the data assuming a
single class of receptors with one affinity state. The solid line
is the best fit calculated from the same data assuming the
receptor exists in two affinity states. Least squares analysis
demonstrates that the two affinity models provides a statisti-
cally better fit for the data (P < 0.001). The affinitiesderived
for the two sites were 1 .6 nM and 38.0 nM respectively with
21 % of the receptors representing the high affinity form.
Averages from 10 computer modeled experiments demon-
strated that 23.3 ± 0.1% of the receptors had an high affinity
with a KD = 1 .5 ± 0.4 nM and the low affinity receptors had
a KD = 25 .5 ± 11 nM. The KD of the low affinity site in
membranes is statistically indistinguishable from the single
affinity observed in intactcell preparations. Scatchard analysis
of this same data was curvilinear, as expected for a heteroge-
neous population of receptors. Assuming the curvilinear plot
was due to two noninteracting receptor populations, two
affinities can be estimated to be 2.1 and 19.1 nM with -27%
of the receptors in the high affinity state.
Effect of Guanine Nucleotides on FML(3H]P
Binding in Membranes
To study the effects of guanine nucleotides on FML[3H]P
binding, we preincubated membranes for 20 min at 25°C with
the nonhydrolyzable derivative of GTP, p[NH]ppG, or with
buffer alone. Fig. 3 shows that the binding of FML[3H]P is
decreased in the presence of 10-4 M p[NH]ppG. This decrease
in binding appears to result from a conversion ofhigh affinity
receptors to low affinity receptors and not from a decrease in
total receptor sites. Totalbinding in the presence of guanine
nucleotide was diminished because the binding isotherms
were carried out to 40 nM FML[3H]P, a dose that occupies a
maximum of -60% ofthe low affinity sites. When the specific
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FIGURE 2 Binding isotherm of FML['H]P to macrophage mem-
brane preparations. The dotted line represents a one site fit to the
data while the solid line represents a two site fit to the same data.
The fit derived from a two site model was significantly better (P <
0.001) than that derived from a one site model. The lower line (0)
is nonspecific binding. The two affinities derived from this experi-
ment are 1 .6 and 38.0 nM with 21% high affinity sites.
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FIGURE 3 Binding isotherms of FML['H]P to macrophage mem-
brane preparations in the presence and absence of p[NH]ppG.
Membranes were preincubated for 20 min at 25*C with buffer
alone or with 10-4 M p[NH]ppG. 0, total binding in the presence
of p[NH]ppG; O, total binding in buffer alone. 0, nonspecific
binding. The reduction in binding is due to a shift from 29.4% high
affinity sites in buffer alone to 8.7% in the presence of p[NH]ppG.
binding data are extrapolated to complete saturation using
SCTFIT, both treated and untreated membrane preparations
had approximately the same number of receptors (treated:
0.133 ± 0.014 nM; untreated: 0.143 ± 0.020 nM). The total
number of high affinity receptors was decreased from 29.4 to
8.7% with a concomitant increase in lowaffinity sites. In this,
plus three other experiments, the average number of high
affinity sites was reduced from 23.2 ± 0.2 to 2.3 ± 0.8% .
There was no significant change in the KD of the high (KDH)
or low affinity (KDL) sites following incubation with p[NH]
ppG (KDH = 1 .92 ± 0.86 vs. 1 .03 ± 0.96; KDL = 23.2 ± 12.49
vs. 30.0 ± 8.12, respectively).
Specificity of Guanine Nucleotide Effect
on Binding
Other nucleotides were tested to determine the specificity
ofthe p[NH]ppG effect on FML['H]P binding. Table I sum-
marizes the results as the percent decrease in high affinity
binding sites produced by each nucleotide tested as deter-
mined by analysis ofdetailed binding isotherms. The guanine
nucleotide triphosphates p[NH]ppG, GTPyS, and GTP sig-
nificantly decreased high affinity binding as did GDP to a
lesser degree while GMP had no effect. Neither ATP, its
nonhydrolyzable derivative p[NH]ppA nor CTP had any
significant effect on binding. The guanine nucleotides in-
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TABLE I
Effect of Nucleotides on Expression of High Affinity Sites
% Decrease of high affinity
Nucleotide added*
￿
binding sites=
None
￿
-
p[NH]ppG
￿
100
GTPyS
￿
90.1
GTP
￿
79.4
GDP
￿
45 .5
GMP
￿
0
p[NH]ppA
￿
11.6
ATP
￿
0
CTP
￿
15
*Membranes were preincubated for 20 min at 25°C with 10-` M of the
indicated nucleotide. Nucleotides were present during the binding assay.
' The indicated values represent the percent decrease of high affinity binding
sites for each nucleotide as compared with the buffer control. The percent
high affinity sites for each experimental condition was determined by
computer analysis of 20 point binding isotherms. Each of the above deter-
minations was repeated at least once with similar results.
z "
O á
50
40
m= 30
xû
DISCUSSION
10
0
-8 -7 -6 -5 -4
log [NUCLEOTIDE], M
FIGURE 4
￿
Dose response effects of nucleotides on FML['H]P bind-
ing to membrane preparations. The membranes were preincubated
with the indicated concentration of nucleotide at 25*C for 20 min,
then 8.5 nM FML['H]P was added. ", p[NH]ppG . A, GTPyS. 0,
GTP. *, ATP. O, p[NH]ppA. The data is plotted as the % inhibition
of specific binding.
hibited FML[3H]P binding in a dose response fashion as is
indicated in Fig. 4. The nonhydrolyzable derivatives of GTP
were the most potent inhibitors of FML['H]P binding fol-
lowed by GTP. The EC50 for the nonhydrolyzablederivatives
of GTP were -5 x 10'6 M while the EC50 for GTP was 5 x
10-5 M. Neither ATP nor p[NH]ppA had an observable effect
on binding at concentrations as high as 10-4 M.
Viable guinea pig macrophages contain specific receptors for
oligopeptide chemotactic factors on their surfaces (14). To
characterize the regulation of this receptor, we performed
detailed binding studies of FML['H]P to intact cells and to
macrophage membrane preparations. Analysis of data with
intact macrophages indicates a homogenous class of receptors
with a single affinity of 18 ± 4.6 nM and 15,300 ± 1,800
receptors per cell. These results are in agreement with those
previously reported using conventional Scatchard analysis
(14). Similar to intact cells, macrophage membranes bound
FML['H]P in a specific and saturable fashion. The specificity
ofthe membrane receptor for a series of N-formylated oligo-
peptides was identical to the receptor on intact macrophages
(14). In contrast to intact cells however, membrane binding
data was most consistent with a heterogeneous population ofreceptors. Heterogeneous binding of the N-formylated pep-
tidesto human and rabbit polymorphonuclear leukocytes has
also been recently reported (7, 9, 13). In the present study
using macrophage membrane preparations, two classes of
receptors were distinguished by two affinities with KD of 1 .5
± 0.4 nM and 25 .5 ± 11 .0 nM, respectively. An average of
23.3 ± 0.1 % of the receptors expressed the high affinity state.
The single affinity observed in the intact macrophage is not
statistically distinguishable from the lower affinity site in
membranes.
Heterogeneous receptor sites have been demonstrated in
other hormone-receptor systems. For example, in the adre-
nergic and cholinergic receptors, guanine nucleotides have
been shown to regulate receptor binding and to be required
for stimulus-response coupling (11, 17, 19). The effects of
guanine nucleotides on FML['H]P binding to macrophage
membranes were therefore examined. The data show that
p[NH]ppG, when present during binding, produced a 90.1
reduction in the percentage of high affinity sites without a
change in totalreceptor number. Thesedata imply that p[NH]
ppG prevents the conversion of low affinity to high affinity
sites and/or converts high affinity sites to low affinity. Other
guanine nucleotides tested GTP, GDP, and the nonhydrolyz-
able derivative GTP-yS produced similar effects on binding
while GMP, ATP, p[NH]ppA, and CTP had no effect. Inhi-
bition of binding by the guanine nucleotides was dose de-
pendent and greatest with nonhydrolyzable derivatives of
GTP. These data suggest that at leasta portion ofthe binding
sites detectable in macrophage membranes are an intercon-
vertible class of receptors and that a GTPase is involved in
the regulation of receptor affinity. The possibility that the
detection of high affinity binding sites in the membranes was
due to a unique intracellular pool of receptors cannot be
excluded since the membrane preparations used contained ß-
glucuronidase, a lysosomal marker. However, the convertibil-
ity of the high affinity to low affinity sites with guanine
nucleotides indicates that the former are not a unique popu-
lation of receptors. In addition, in experiments not shown,
disrupted macrophages were fractionated on discontinuous
sucrose density (10, 18) and Percoll density gradients (1). In
all cases, specific FML['H]P bindingwas seen only in fractions
containing the plasma membrane marker 5'nucleotidase. In
none of the fractions however could plasma membranes be
obtained free of ß-glucuronidase activity.
The data presented here resemble certain characteristics of
neurotransmitter receptors. In the ß-adrenergic receptor a
single affinity is observed in the intact cells while membranes
display a second higher affinity that is converted to a low
affinity form by guanine nucleotides (17). Transduction
mechanismsof the ß-adrenergic receptor have been shown to
be mediated by a nucleotide regulatory protein (N-protein)
(16). A ternary complex model similar to that proposed for
the ß-adrenergic system (17) is consistent with the FML['H]
P binding data presented here and offers a possible explana-
tion for the guanine nucleotide effect. Fig. 5 presents a func-
tional model adapted for the chemotactic factor receptor on
macrophages. In this model, receptor occupancy by a che-
moattractant (CTX) facilitates the substitution of GDP by
GTP on a nucleotide regulatory unit (N), thereby providing
N-GTP to activate an effector (E --* E*). The affinity of the
receptor is determined allosterically via its binding to the N-
unit. When coupled to the N-unit carrying GDP or GTP, the
receptor expresses a low affinity state. We postulate that the
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FIGURE 5
￿
Postulated model for the interaction of guanine nucleo-
tides with a nucleotide regulatory protein and the chemoattractant
(CTX)-receptor complex. It is proposed that the affinity of the
receptor is affected by its coupling to a regulatory unit, N, which
binds guanine nucleotides. The transient high affinity state (R') may
occur when the receptor is bound to free N. (E and E*) The
unmodified and modified forms of the putative effector molecule.
high affinity state of the receptor (R') is manifest when the
receptor is either free of N or bound to N in the absence of
any guanine nucleotide. Similar findings are present in human
granulocyte membranes suggesting that the proposed model
may be generally relevant to chemotactically responsive cells
(8). Moreover, we have recently shown that guanine triphos-
phates are required for the activation of adenylate cyclase by
prostaglandins in guinea pig macrophage membranes (19).
The model of the chemoattractant receptor proposed here
is consistent with the detection of only a single low affinity
class of receptors in intact macrophages since the levels of
guanine nucleotides in the cells are sufficient to allow receptor
interconvertibility in situ and thus expression of one affinity.
The levels of GTP and GDP in guinea pig macrophages were
114 and 67 pM, respectively. In membrane preparations
however, when the guanine nucleotides are removed by wash-
ing, an additional population of receptors can be detected
since interconvertibility is blocked. The effector(s) for the
chemoattractant receptor is yet unknown but likely candidates
would include a methyltransferase, a phospholipase, a protein
kinase or perhaps adenylate cyclase. In any case, guanine
nucleotide modulation of FML['H]P binding implies a mech-
anism for the regulation of stimulus-response coupling for
chemoattractant receptors on macrophages.
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